Category: Media

Scott Chudnoff, MD, highlights the benefits of Fembloc for permanent contraception

Femasys Announces Third Quarter Financial Results for 2025

Femasys Advances Global Growth with Second Partner Order for FemBloc® in Europe

How Femasys Is Using Innovation to Rethink Permanent Birth Control

FDA grants IDE approval for FemBloc nonsurgical permanent birth control

Femasys Secures FDA Approval to Advance Final FemBloc® Trial Phase and $12 Million Financing, with Potential to Reach $58 Million

Meet the metro Atlanta woman who invented a new permanent birth control

The Future of Fertility and Non-Surgical Birth Control with Kathy Lee-Sepsick

Femasys’ Roadmap for FemBloc in Europe

Suwanee company raising millions following approval of birth-control product